blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2094249

EP2094249 - TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.02.2017
Database last updated on 08.04.2026
Most recent event   Tooltip21.09.2018Lapse of the patent in a contracting state
New state(s): MT		published on 24.10.2018  [2018/43]
Applicant(s)For all designated states
LTS LOHMANN Therapie-Systeme AG
Lohmannstrasse 2
56626 Andernach / DE
[2016/15]
Former [2009/36]For all designated states
LTS LOHMANN Therapie-Systeme AG
Lohmannstrasse 2
56626 Andernach / DE
Inventor(s)01 / HILLE, Thomas
Steinstr.39
56567 Neuwied / DE
02 / HORSTMANN, Michael
Fürst-Friedrich-Karl-Str. 9
56564 Neuwied / DE
03 / MÜLLER, Walter
Hindenburgwall 12
56626 Andernach / DE
 [2009/38]
Former [2009/36]01 / HILLE, Thomas
Thielenstr. 10
56073 Koblenz / DE
02 / HORSTMANN, Michael
Fürst-Friedrich-Karl-Str. 9
56564 Neuwied / DE
03 / MÜLLER, Walter
Hindenburgwall 12
56626 Andernach / DE
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2014/02]Maiwald Patentanwalts GmbH
Elisenhof
Elisenstrasse 3
80335 München / DE
Former [2012/08]Siemund, Volker, et al
LTS Lohmann Therapie-Systeme AG Patentabteilung Postfach 1525
56605 Andernach / DE
Former [2009/36]Schmidt, Werner
LTS LOHMANN Therapie-Systeme AG, Lohmannstrasse 2
56626 Andernach / DE
Application number, filing date07846537.407.11.2007
[2009/36]
WO2007EP09622
Priority number, dateDE2006105473121.11.2006         Original published format: DE102006054731
[2009/36]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2008061625
Date:29.05.2008
Language:DE
[2008/22]
Type: A2 Application without search report 
No.:EP2094249
Date:02.09.2009
Language:DE
The application published by WIPO in one of the EPO official languages on 29.05.2008 takes the place of the publication of the European patent application.
[2009/36]
Type: B1 Patent specification 
No.:EP2094249
Date:13.04.2016
Language:DE
[2016/15]
Search report(s)International search report - published on:EP18.09.2008
ClassificationIPC:A61K9/70, A61K31/485
[2009/36]
CPC:
A61K31/485 (EP,KR,US); A61K9/70 (KR); A61K47/12 (US);
A61K9/7053 (US); A61K9/7069 (US); A61K9/7084 (EP,US);
A61K9/7092 (US); A61M37/00 (US); A61P25/00 (EP);
A61P25/04 (EP); A61P25/32 (EP); A61P25/36 (EP);
A61P29/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/15]
Former [2009/36]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR VERABREICHUNG DES WIRKSTOFFS BUPRENORPHIN[2009/36]
English:TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE[2009/36]
French:SYSTÈME THÉRAPEUTIQUE TRANSDERMIQUE DESTINÉ À L'ADMINISTRATION DE L'AGENT ACTIF BUPRÉNORPHINE[2009/36]
Entry into regional phase17.03.2009National basic fee paid 
17.03.2009Designation fee(s) paid 
17.03.2009Examination fee paid 
Examination procedure19.03.2009Examination requested  [2009/36]
02.10.2009Despatch of a communication from the examining division (Time limit: M04)
04.02.2010Reply to a communication from the examining division
02.11.2015Communication of intention to grant the patent
24.02.2016Fee for grant paid
24.02.2016Fee for publishing/printing paid
24.02.2016Receipt of the translation of the claim(s)
Divisional application(s)EP14169050.3  / EP2769714
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.10.2009
Opposition(s)16.01.2017No opposition filed within time limit [2017/12]
Fees paidRenewal fee
24.11.2009Renewal fee patent year 03
23.11.2010Renewal fee patent year 04
23.11.2011Renewal fee patent year 05
23.11.2012Renewal fee patent year 06
28.11.2013Renewal fee patent year 07
25.11.2014Renewal fee patent year 08
24.11.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG13.04.2016
EE13.04.2016
IS13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
MT13.04.2016
[2018/43]
Former [2018/38]BG13.04.2016
EE13.04.2016
IS13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
Former [2018/32]EE13.04.2016
IS13.04.2016
LT13.04.2016
LV13.04.2016
MC13.04.2016
Former [2017/10]EE13.04.2016
LT13.04.2016
LV13.04.2016
Former [2016/51]LT13.04.2016
LV13.04.2016
Former [2016/46]LT13.04.2016
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.